Dec 16 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and Metachromatic Leukodystrophy, to the federal newborn screening list to enable early treatment, the Department of Health and Human Services said.
The decision updates the Recommended Uniform Screening Panel (RUSP), which guides state-level newborn screening programs, following a scientific review and public comment process.
Early detection of Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD) will allow children to receive FDA-approved therapies at the most effective time, helping slow disease progression and preserve quality of life, the HHS said.
DMD, a rare genetic disorder, causes muscle degeneration, while MLD affects the brain and nervous system, which leads to loss of motor and cognitive function and early death.
Most children with DMD or MLD are diagnosed at age four or five, when significant muscle loss or neurological decline has already occurred, the HHS said.
The agency said that screening at birth could reduce years-long diagnostic delays, repeated specialist visits, and the financial and emotional strain often associated with rare diseases.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini Ganguli)
First SpaceX booster for upgraded Starship fails during test in Texas- 2 new malaria treatments announced as drug resistance grows
- Astonishing interstellar comet captured in new images by NASA Mars missions
- Do you lean your seat back on the plane? These travel pros — and real-life couple — won't do it.
- A Timeline of Rising Antisemitism in Australia
- Equality requires universal draft, participation in economy and workforce, MK Liberman says
- RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- Authentic Urban areas: Rich Legacy and Lively Societies
- Virtual Domains d: A Survey of \Inundation and Ongoing interaction Mechanics\ Computer game
